A 3-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408
Evens, Andrew M, Hong, Fangxin, Habermann, Thomas M., Advani, Ranjana H., Gascoyne, Randy D., Witzig, Thomas E., QUON, ANDREW, Ranheim, Erik A, Ansell, Stephen M, Cheema, Puneet Singh, Dy, Philip A, OJournal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-20-1345
Date:
June, 2020
File:
PDF, 680 KB
2020
File converter
More search results
More benefits 
